Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells
about
Prostate Cancer: Epigenetic Alterations, Risk Factors, and TherapyHDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis.A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1.Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagyEpigenetic modifications in prostate cancer.Hybrids from Farnesylthiosalicylic Acid and Hydroxamic Acid as Dual Ras-Related Signaling and Histone Deacetylase (HDAC) Inhibitors: Design, Synthesis and Biological Evaluation.Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.Schlafen 12 expression modulates prostate cancer cell differentiation.Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells.HDAC1 controls CIP2A transcription in human colorectal cancer cells.Rescue of cell cycle progression in BRAFV600E inhibitor-resistant human melanoma by a chromatin modifier.The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
P2860
Q28073470-D074503B-7AD2-4E77-9A40-3615C2259D00Q34885424-12EBD388-88AA-400E-9B64-023B3A88CD99Q36015707-83578E1F-C7E8-401F-B9E6-89CF5B5A77F9Q37325233-4A3857B3-2B21-4CD7-ADBF-A80E4A4638E3Q37644099-8C5B840D-A827-4274-A800-4F138CC7B2CFQ38261747-F1FD3BAC-BAEC-4852-B8A3-B9FDEADA89F2Q38886102-90E5DCB5-79A9-4D4A-95B1-46BDCA655E3CQ38908272-9B4F6869-0B38-4D1B-BF8F-141A3B012500Q39001150-0D3C4488-E65D-43FB-9BF8-3B34C205792CQ39297835-11EF9E19-ABF7-47BC-93D9-FD5AD7A96F35Q41225033-1521BB98-CDC4-4C14-8D55-1F97C5AF7166Q46103191-6FAD0C0D-30F5-4C2F-BBD8-C071F306182BQ46280254-2EF02E1F-D983-437B-9E30-860566F01A92
P2860
Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effectiveness of the histone d ...... C3 human prostate cancer cells
@ast
Effectiveness of the histone d ...... C3 human prostate cancer cells
@en
Effectiveness of the histone d ...... C3 human prostate cancer cells
@nl
type
label
Effectiveness of the histone d ...... C3 human prostate cancer cells
@ast
Effectiveness of the histone d ...... C3 human prostate cancer cells
@en
Effectiveness of the histone d ...... C3 human prostate cancer cells
@nl
prefLabel
Effectiveness of the histone d ...... C3 human prostate cancer cells
@ast
Effectiveness of the histone d ...... C3 human prostate cancer cells
@en
Effectiveness of the histone d ...... C3 human prostate cancer cells
@nl
P2093
P2860
P3181
P1433
P1476
Effectiveness of the histone d ...... C3 human prostate cancer cells
@en
P2093
Anna Laurenzana
Cristina Cellai
Francesco Paoletti
Manjola Balliu
Maria Novella Romanelli
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0058267
P407
P577
2013-01-01T00:00:00Z